pyrimethamine has been researched along with Infection, Mycobacterium avium-intracellulare in 6 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pyrimethamine in combination with a fixed concentration of dapsone at 0." | 1.29 | Enhanced in vitro activity of pyrimethamine in combination with dapsone against Mycobacterium avium complex. ( Cynamon, MH; Meyer, SC; Shah, LM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opravil, M | 1 |
| Pechère, M | 1 |
| Lazzarin, A | 1 |
| Heald, A | 1 |
| Rüttimann, S | 1 |
| Iten, A | 1 |
| Furrer, H | 1 |
| Oertle, D | 1 |
| Praz, G | 1 |
| Vuitton, DA | 1 |
| Shah, LM | 1 |
| Meyer, SC | 1 |
| Cynamon, MH | 1 |
| Asencio Marchante, R | 1 |
| Lissen Otero, E | 1 |
| Cheng, B | 1 |
| Walker, MJ | 1 |
| Hardy, WD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pyrimethamine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
2 trials available for pyrimethamine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Topics: Adult; CD4 Lymphocyte Count; Dapsone; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Huma | 1995 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
4 other studies available for pyrimethamine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Enhanced in vitro activity of pyrimethamine in combination with dapsone against Mycobacterium avium complex.
Topics: Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Synergism; Humans; Microbial Sensitivity Tes | 1996 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal A | 2001 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |
Opportunistic infections studies update.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Atovaquone; Candidiasi | 1995 |